Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • EGFR
    (4)
  • Apoptosis
    (1)
  • Drug Metabolite
    (1)
  • Others
    (12)
TargetMol | Tags By ResearchField
  • Cancer
    (2)
  • Respiratory System
    (1)
Filter
Search Result
Results for "

dacomitinib

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    16
    TargetMol | All_Pathways
  • Isotope Products
    1
    TargetMol | Isotope_Products
  • Cell Research
    10
    TargetMol | Cell_Research_Reagents
  • Reference Standards
    1
    TargetMol | Standard_Products
Dacomitinib
PF-299804, PF299, PF-00299804
T24831110813-31-4
Dacomitinib (PF299)(PF299804; PF-00299804) is a highly selective, orally bioavailable small-molecule inhibitor of the HER family of tyrosine kinases with IC50 of 6, 45.7 and 73.7 nM for EGFR, ERBB2, and ERBB4, respectively.
  • $32
In Stock
Size
QTY
TargetMol | Citations Cited
Dacomitinib metabolite M2
UNII-SOA52D3NLL, Dacomitinib cysteine conjugate
T239501262034-38-7
Dacomitinib metabolite M2 is also known as Dacomitinib cysteine conjugate. Dacomitinib inhibits both the wild-type (WT) EGFR and EGFR T790M.
  • Inquiry Price
3-6 months
Size
QTY
Dacomitinib impurity 8
Dacomitinib Impurity SFXJ
TYD-050222119689-75-5
Dacomitinib impurity 8 is an impurity found in Dacomitinib.
  • Inquiry Price
Inquiry
Size
QTY
Dacomitinib impurity 9
Dacomitinib Impurity SFAJ
TYD-053192117703-26-9
Dacomitinib impurity 9 is a byproduct associated with Dacomitinib.
  • Inquiry Price
Inquiry
Size
QTY
Dacomitinib hydrate
PF-299804, PF299804, PF-00299804, PF00299804, PF 299804, PF 00299804
T199651042385-75-0
Dacomitinib hydrate (PF 299804) is a highly selective and second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor family of tyrosine kinases. Dacomitinib specifically and irreversibly binds to and inhibits human EGFR subtypes, resulting in inhibition of proliferation and induction of apoptosis in EGFR-expressing tumor cells.
  • $43
In Stock
Size
QTY
O-Desmethyl dacomitinib
PF-05199265
T2149822468202-15-3
O-Desmethyl dacomitinib (PF-05199265) is the primary circulating metabolite of Dacomitinib and acts as a pan-ErbB tyrosine kinase inhibitor, targeting epidermal growth factor receptors. The exposure level of O-Desmethyl dacomitinib is significantly lower than that of Dacomitinib, and its formation is highly dependent on CYP2D6 enzyme activity.
  • Inquiry Price
10-14 weeks
Size
QTY
Dacomitinib impurity 16
TYD-049952803456-91-7
Dacomitinib impurity 16 is a known impurity of Dacomitinib.
  • Inquiry Price
Inquiry
Size
QTY
Dacomitinib impurity 4
TYD-050052803478-66-0
Dacomitinib impurity 4 is an impurity associated with Dacomitinib.
  • Inquiry Price
Inquiry
Size
QTY
Dacomitinib impurity 3
TYD-050082190490-31-2
Dacomitinib impurity 3 is a contaminant found in Dacomitinib.
  • Inquiry Price
Inquiry
Size
QTY
Dacomitinib impurity 13
TYD-05012
Dacomitinib impurity 13 is an impurity associated with dacomitinib.
  • Inquiry Price
Inquiry
Size
QTY
Dacomitinib impurity 11
TYD-05036
Dacomitinib impurity 11 is an impurity of Dacomitinib.
  • Inquiry Price
Inquiry
Size
QTY
Dacomitinib impurity 12
TYD-051842803451-99-0
Dacomitinib impurity 12 is an impurity of Dacomitinib.
  • Inquiry Price
Inquiry
Size
QTY
Dacomitinib impurity 1
TYD-052322803478-55-7
Dacomitinib impurity 1 is an impurity associated with Dacomitinib.
  • Inquiry Price
Inquiry
Size
QTY
Dacomitinib impurity 14
TYD-052881454307-45-9
Dacomitinib Impurity 14 is a byproduct associated with Dacomitinib.
  • Inquiry Price
Inquiry
Size
QTY
Dacomitinib-[D10] Dihydrochloride Salt (Standard)
TMSM-6668
Dacomitinib-[D10] Dihydrochloride Salt (Standard) is a reference standard of Dacomitinib-[D10] Dihydrochloride Salt intended for quantitative analysis, quality control, and related biochemical research applications.
  • $2,150
4-6 weeks
Size
QTY
Dacomitinib Intermediate 2
N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine
T67152179552-74-0
Dacomitinib Intermediate 2 (N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine) has anticancer activity and can be used to study lung cancer.
  • $35
In Stock
Size
QTY
TargetMol | Inhibitor Sale